|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6850 USD | +0.75% |
|
-1.45% | -49.26% |
| 07-01 | CbdMD Launches Oasis Mixer, A Hemp-Derived Zero-Proof THC Spirit | CI |
| 06-16 | CbdMD, Inc. Appoints Wade Brown as Chief Marketing Officer | CI |
| Market Cap | 7.19M 6.29M 5.78M 5.39M 10.21M 685M 10.37M 69.36M 26.96M 337M 26.99M 26.41M 1.16B | P/E 2026 * |
-3.61x | P/E 2027 * | -9.79x |
|---|---|---|---|---|---|
| Enterprise Value | 7.19M 6.29M 5.78M 5.39M 10.21M 685M 10.37M 69.36M 26.96M 337M 26.99M 26.41M 1.16B | EV / Sales 2026 * |
0.32x | EV / Sales 2027 * | 0.31x |
| Free-Float |
89.32% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: cbdMD, Inc.
| 1 day | +0.75% | ||
| 1 week | -1.45% | ||
| Current month | +1.78% | ||
| 1 month | -8.67% | ||
| 3 months | -6.55% | ||
| 6 months | -40.95% | ||
| Current year | -49.26% |
| 1 week | 0.66 |  | 0.71 |
| 1 month | 0.65 | | 0.74 |
| Current year | 0.63 | | 1.34 |
| 1 year | 0.47 | | 2.56 |
| 3 years | 0.47 | | 13.84 |
| 5 years | 0.47 | | 1,087.2 |
| 10 years | 0.47 | | 2,606.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
T. Kennedy
CEO | Chief Executive Officer | 47 | 01/03/2023 |
Zeb Booker
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2019 |
Sibyl Swift
CTO | Chief Tech/Sci/R&D Officer | 45 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Jeffrey Porter
BRD | Director/Board Member | 66 | 10/04/2025 |
T. Kennedy
BRD | Director/Board Member | 47 | 18/12/2024 |
Bakari Sellers
BRD | Director/Board Member | 41 | 01/03/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 04-14 | Free | Chief Technology Officer | 1,572 | 0.0150% | ||
| 04-14 | Free | Director | 1,572 | 0.0150% | ||
| 04-14 | Free | Director | 1,572 | 0.0150% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.75% | -1.45% | -20.35% | -94.01% | 7.19M | |
| +1.86% | +0.48% | +55.50% | +163.08% | 1,082B | |
| +3.57% | +3.29% | +68.60% | +61.03% | 633B | |
| +3.99% | +3.05% | +37.93% | +93.37% | 461B | |
| +3.86% | +1.64% | +31.35% | +24.29% | 338B | |
| -0.56% | +0.96% | +39.86% | +36.64% | 299B | |
| -0.08% | +1.30% | +30.37% | +44.02% | 291B | |
| -1.54% | +2.81% | -27.56% | -39.45% | 222B | |
| +3.55% | +4.41% | +25.45% | +66.28% | 202B | |
| +4.21% | +2.65% | +17.47% | +71.11% | 163B | |
| Average | +1.96% | +3.86% | +25.86% | +42.64% | 369.24B | |
| Weighted average by Cap. | +2.25% | +5.53% | +41.78% | +83.01% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 22.15M 19.37M 17.8M 16.59M 31.47M 2.11B 31.94M 214M 83.06M 1.04B 83.15M 81.37M 3.57B | 23.26M 20.33M 18.69M 17.42M 33.04M 2.21B 33.54M 224M 87.21M 1.09B 87.31M 85.44M 3.75B |
| Net income | -1.9M -1.66M -1.53M -1.42M -2.7M -181M -2.74M -18.34M -7.13M -89.02M -7.14M -6.99M -307M | -902K -789K -725K -675K -1.28M -85.88M -1.3M -8.7M -3.38M -42.22M -3.39M -3.31M -145M |
| Net Debt | - | - |
Employees
42
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/07/26 | $0.6850 | +0.75% | 72,420 |
| 01/07/26 | $0.6799 | +1.03% | 106,658 |
| 30/06/26 | $0.6730 | -3.86% | 122,972 |
| 29/06/26 | $0.7000 | +0.70% | 265,488 |
| 26/06/26 | $0.6951 | -1.12% | 233,106 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.6850USD
Average target price
2.000USD
Spread / Average Target
+191.97%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- YCBD Stock
Select your edition
All financial news and data tailored to specific country editions
